COLUMBUS, Ohio – Rebecca Nagy (43082), a certified genetic counselor and researcher at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, has been elected president of the National Society of Genetic Counselors (NSCG).
Nagy will serve as president-elect starting Jan. 1, and assume the presidency for one year effective Jan. 1, 2013. Nagy, a member of the society since 1994, is finishing a two-year term as its secretary/treasurer. She also co-chaired the society’s familial cancer special interest group in 2008-09, representing more than 500 cancer genetic counselors nationally on issues relating to this discipline.
NSCG is the leading voice, authority and advocate for the genetic counseling profession, representing more than 2,300 masters-level health professionals. The society advances the roles of genetic counselors in health care by fostering education, research and public policy to ensure the availability of quality genetic services.
Nagy, who has been a genetic counselor since 1997, is an assistant professor in Ohio State’s Department of Internal Medicine, Division of Human Genetics. Her research interests include genetic predisposition to non-medullary thyroid cancer.
Her clinical duties include providing comprehensive cancer genetic consultations to individuals and families with a history of cancer. Cancer Genetic consultation requires tremendous documentation of cancers in the family, risk assessment, screening recommendations, and incorporation of genetic testing as necessary. More than 400 individuals/families are seen each year in the Clinical Cancer Genetics clinic at Ohio State.
Nagy holds a bachelor’s degree in biology from the University of Iowa and a master’s degree in genetics counseling from the University of Minnesota. She also is a member of the American Society of Human Genetics.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (cancer.osu.edu) strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State’s cancer program as “exceptional,” the highest rating given by NCI survey teams. As the cancer program’s 210-bed adult patient-care component, The James is a “Top Hospital” as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report.
Contact: Eileen Scahill, Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu